Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifemd Inc (LFMD)

Lifemd Inc (LFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 155,479
  • Shares Outstanding, K 48,136
  • Annual Sales, $ 212,450 K
  • Annual Income, $ -18,880 K
  • EBIT $ 1 M
  • EBITDA $ 11 M
  • 60-Month Beta 1.36
  • Price/Sales 0.73
  • Price/Cash Flow N/A
  • Price/Book 45.48

Options Overview Details

View History
  • Implied Volatility 87.59% (+18.37%)
  • Historical Volatility 66.25%
  • IV Percentile 60%
  • IV Rank 34.82%
  • IV High 134.13% on 04/04/25
  • IV Low 62.73% on 08/15/25
  • Expected Move (DTE 24) 0.43 (13.55%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 253
  • Volume Avg (30-Day) 392
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 25,548
  • Open Int (30-Day) 24,245
  • Expected Range 2.77 to 3.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate 0.10
  • Low Estimate -0.12
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.18 +0.63%
on 12/22/25
4.05 -21.09%
on 11/24/25
-0.65 (-16.88%)
since 11/21/25
3-Month
3.18 +0.63%
on 12/22/25
7.32 -56.28%
on 10/03/25
-3.35 (-51.15%)
since 09/22/25
52-Week
3.18 +0.63%
on 12/22/25
15.84 -79.80%
on 06/23/25
-1.84 (-36.51%)
since 12/20/24

Most Recent Stories

More News
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on both...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Reports Third Quarter 2025 Results

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30%...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced a new, lower cash-pay price for GLP-1 medications,...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD to Participate in the BTIG Digital Health Forum

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced its participation in the virtual BTIG Digital...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced the sale of its majority ownership interest...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options

LFMD : 3.20 (-0.93%)
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD ...

LFMD : 3.20 (-0.93%)
LFMD FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of LifeMD Upcoming Lead Plaintiff Deadline on Monday, October 27, 2025

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options...

LFMD : 3.20 (-0.93%)
Class Action Filed Against LifeMD, Inc. (LFMD) Seeking Recovery for Investors - Contact The Gross Law Firm

NEW YORK , Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).

LFMD : 3.20 (-0.93%)

Business Summary

LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer...

See More

Key Turning Points

3rd Resistance Point 3.39
2nd Resistance Point 3.35
1st Resistance Point 3.27
Last Price 3.20
1st Support Level 3.15
2nd Support Level 3.11
3rd Support Level 3.03

See More

52-Week High 15.84
Fibonacci 61.8% 11.00
Fibonacci 50% 9.51
Fibonacci 38.2% 8.02
Last Price 3.20
52-Week Low 3.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar